Xencor, Inc. (XNCR)
24.72
+0.13
(+0.53%)
USD |
NASDAQ |
Sep 18, 16:00
24.72
0.00 (0.00%)
After-Hours: 20:00
Xencor Cash from Investing (Quarterly) : 85.12M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 85.12M |
| March 31, 2026 | 26.68M |
| December 31, 2025 | 72.90M |
| September 30, 2025 | 14.67M |
| June 30, 2025 | 40.48M |
| March 31, 2025 | 11.94M |
| December 31, 2024 | 57.25M |
| September 30, 2024 | -163.46M |
| June 30, 2024 | 66.02M |
| March 31, 2024 | 32.32M |
| December 31, 2023 | -202.63M |
| September 30, 2023 | 45.33M |
| June 30, 2023 | -1.405M |
| March 31, 2023 | 48.14M |
| December 31, 2022 | 24.55M |
| September 30, 2022 | 3.125M |
| June 30, 2022 | -75.64M |
| March 31, 2022 | -71.76M |
| December 31, 2021 | 7.86M |
| September 30, 2021 | -38.85M |
| June 30, 2021 | -53.31M |
| March 31, 2021 | 38.05M |
| December 31, 2020 | 78.78M |
| September 30, 2020 | -50.56M |
| June 30, 2020 | 59.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 12.56M |
| December 31, 2019 | 15.73M |
| September 30, 2019 | 22.06M |
| June 30, 2019 | -102.43M |
| March 31, 2019 | 13.67M |
| December 31, 2018 | 6.866M |
| September 30, 2018 | 5.862M |
| June 30, 2018 | -190.17M |
| March 31, 2018 | 12.67M |
| December 31, 2017 | 8.939M |
| September 30, 2017 | 4.933M |
| June 30, 2017 | 9.439M |
| March 31, 2017 | 8.553M |
| December 31, 2016 | -104.27M |
| September 30, 2016 | -127.66M |
| June 30, 2016 | 8.623M |
| March 31, 2016 | 9.66M |
| December 31, 2015 | -41.69M |
| September 30, 2015 | 6.933M |
| June 30, 2015 | -101.29M |
| March 31, 2015 | -49.06M |
| December 31, 2014 | -0.587M |
| September 30, 2014 | -0.573M |
| June 30, 2014 | -0.675M |
| March 31, 2014 | -0.448M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| UroGen Pharma Ltd. | 1.185M |
| MeiraGTx Holdings Plc | -23.63M |
| Regeneron Pharmaceuticals, Inc. | -92.70M |
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| MacroGenics, Inc. | 27.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -55.66M |
| Cash from Financing (Quarterly) | 1.031M |
| Free Cash Flow | -208.28M |
| Free Cash Flow Per Share (Quarterly) | -0.7408 |
| Free Cash Flow to Equity (Quarterly) | -51.14M |
| Free Cash Flow to Firm (Quarterly) | -48.91M |
| Free Cash Flow Yield | -11.23% |